Last updated: December 15, 2023
Sponsor: Klinikum Klagenfurt am Wörthersee
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glaucoma
Surgery
Treatment
PreserFlo Microshunt
Clinical Study ID
NCT06174324
S2021-29
Ages 18-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with insufficient eye pressure control despite IOP (intraocularpressure)-lowering therapy
- Diagnosis of POAG (primary open angle glaucoma)
- Diagnosis of PEG (pseudoexfoliation glaucoma)
- Diagnosis of PDG (pigment dispersion glaucoma)
- Diagnosis of NTG (normal tension glaucoma)
- Agreement of patients to participate in the study
Exclusion
Exclusion Criteria:
- Previous glaucoma surgery
- Visual acuity of Nulla Lux
- Poor general condition
- Pregnancy
- Exudative macular degeneration
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: PreserFlo Microshunt
Phase:
Study Start date:
October 12, 2021
Estimated Completion Date:
September 09, 2024
Connect with a study center
KlinikumKlagenfurt
Klagenfurt, 9020
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.